The historical rank and industry rank for Fabino Enterprises's FCF Margin % or its related term are showing as below:
BOM:543444'
s FCF Margin % Range Over the Past 10 Years
Min: -46.29 Med: -2.85 Max: 32.47
Current: 0.83
During the past 8 years, the highest FCF Margin % of Fabino Enterprises was 32.47%. The lowest was -46.29%. And the median was -2.85%.
BOM:543444's FCF Margin % is ranked worse than 54.78% of 962
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs BOM:543444: 0.83
Fabino Enterprises FCF Margin % Related Terms
Fabino Enterprises FCF Margin % Historical Data
* Premium members only.
The historical data trend for Fabino Enterprises's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Enterprises FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Fabino Enterprises's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Enterprises (BOM:543444) has a FCF Margin % of 1.15% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fabino Enterprises and its competitors. According to the industry distribution chart, Fabino Enterprises ranks #527 out of 962 companies in the Drug Manufacturers industry, placing it in the top 54.8%.
Is Fabino Enterprises' FCF Margin % too high?
Fabino Enterprises' current FCF Margin % is 1.15%. The Drug Manufacturers industry median FCF Margin % is 2.51. Fabino Enterprises' value of 1.15% is 54.2% below this industry median. Based on the distribution chart, Fabino Enterprises ranks #527 out of 962 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fabino Enterprises ranks #527 out of 962 companies for FCF Margin %. This places Fabino Enterprises in the lower half of its industry. The industry median FCF Margin % is 2.51. Fabino Enterprises' value of 1.15% is 54.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabino Enterprises's current FCF Margin % of 1.15% is 54.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fabino Enterprises and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabino Enterprises's current FCF Margin % is 1.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current FCF Margin % of 1.15%. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current FCF Margin % is 1.15% and 54.2% below the Drug Manufacturers industry median of 2.51. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current FCF Margin % is 1.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fabino Enterprises (BOM:543444) Overvalued in 2026?
Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued.
The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.
Key valuation signals for BOM:543444:
FCF Margin %: 1.15%
GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
Industry Position: 54.2% below the Drug Manufacturers median (#527 of 962)
No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score
Get the complete analysis for BOM:543444
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543444 has been successfully added to your 
